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Androgenetic alopecia (AGA) is a common heritable polygenic disorder whose genetics is not fully understood,
even though it seems to be X-linked. We carried out an epidemiological survey for AGA on 9,000 people from 8
isolated villages of a secluded region of Sardinia (Ogliastra), and identified a large cohort of affected individuals.
We genotyped 200 cases and 200 controls (mean kinship 0.001) with the 500k chip array and conducted
case–control association analysis on the X chromosome. We identified Xq11-q12 as strongly associated with
AGA. In particular, we found that rs1352015 located 8 kb from the EDA2R gene showed the best result
(P¼ 7.77e7). This region also contains the AR gene, hence we tested both genes in 492 cases and 492 controls.
We found that the non-synonymous SNP rs1385699 on EDA2R gave the best result (P¼ 3.9e19 ) whereas rs6152
on the AR gene is less significant (P¼ 4.17e12). Further statistical analysis carried out by conditioning each gene to the
presence of the other showed that the association with EDA2R is independent while the association with AR seems to
be the result of linkage disequilibrium. These results give insight into the pathways involved in AGA etiology.
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Androgenetic alopecia (AGA) is characterized by hair loss
that affects up to 50% of all males (Hamilton, 1951).
Although it is generally accepted that it is a polygenic
heritable trait, a clearly responsible gene has yet to be
identified (Kuster and Happle, 1984; Ellis et al., 1998). We
carried out an epidemiological survey for AGA in eight
villages of Ogliastra, a secluded area of central Sardinia
(Angius et al., 2001). The population of each village is
characterized by high endogamy, little immigration, and slow
population growth, and there have been few marriage
exchanges among the villages during the centuries. This
was proven both by genealogical reconstructions and through
genetic studies, that is, of mitochondrial DNA. For this
reason, each village can be considered independently of the
others (Fraumene et al., 2003). To calculate prevalence, we
selected males older than 18 years and with a grade higher
than IIv on the Norwood–Hamilton hair-loss scale. We found
that the average mean prevalence in men was 47%, varying
from 39% in the village of Seui to 56% in Talana. Given the
large number of collected samples (9,000), it was possible to
select the most severe cases of AGA. We picked men who
had a baldness grade of at least IV on the Norwood–Hamilton
scale and had onset before 30 years of age. For controls, we
selected men who were at least 40 years old at the time of the
visit and had no evidence of AGA. Using these parameters, we
selected 200 cases and 200 controls; samples were selected in
equal number (25 cases and 25 controls) from each of the eight
villages to avoid population stratification. Within each village
we selected cases and controls so that they were the most
distantly related as possible, and so that cases did not have
greater kinship than controls (averaged mean kinship in
cases¼0.0016, SD¼0.01; average mean kinship in con-
trols¼0.0011, SD¼0.01). The algorithm used, involving
sampling from the many pairwise relationships present in
extended genealogies, is described by Falchi et al. (2004). We
genotyped these samples with the Affymetrix-GeneChip
human mapping 500k array. The minimum call rate for each
individual was 93%; for each single nucleotide polymorphism
(SNP) it was 90%. All individuals participating in the study
signed informed consent forms, and all the samples were taken
in accordance with the Declaration of Helsinki Principles
(http://www.wma.net/e/policy/17-c_e.html). Institutional ap-
proval was not required for experiments.
We decided to investigate the association first on the X
chromosome, not only because previous studies have asso-
ciated this chromosome with AGA but also because, on a first
genome-wide scan, the most positive signal was on this
chromosome. We tested 7,093 SNPs on the whole X chromo-
some using Quasi-likelihood score test for case–contol
(CCQLS) (Bourgain et al., 2003), a software that permits the
correction of the association analysis results by the kinship
matrix. We used this method because the population is
inbred, and, although samples were selected to avoid
spurious association due to kinship, we cannot exclude
cryptic relatedness not accounted for. We used markers with
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minimum allele frequency (MAF) 40.025 in the whole
sample because we did not have enough statistical power to
detect association with rarer variants. We found that several
markers in the Xq11–q12 region (Figure 1, Table S1) were
strongly associated with AGA: in particular, rs1352015 gave
the best result (P¼7.77e7). This result is still significant at the
5% level when adjusted for multiple testing using Bonferroni
correction, giving a corrected P-value of 0.0144, although it
does not reach genome-wide significance (genome-wide
corrected P-value 0.17). The rs1352015 SNP is located 8 kb
outside the 50 end of the EDA2R (EDA-A2 receptor) gene. This
region is close to the androgen receptor gene (AR), whose
intragenic variants (in particular, rs6152) have been
associated with the AGA phenotype (Ellis et al., 2001; Hayes
et al., 2005; Hillmer et al., 2005; Levy-Nissenbaum et al.,
2005). The single AR informative intragenic marker included
in the Affymetrix 500K array was rs4827545, and it gave a
strongly significative P-value (P¼ 6.49e5). Because the
association close to the EDA2R gene was stronger than the
one on the AR gene, we decided to investigate the possible
role of these two genes in the etiology of AGA in our
population. In addition, we also tested rs12558842 because
its P-value was almost as low as that of rs1352015.
To test our results, we selected 492 cases (mean onset
age¼24 years, mean hair-loss grade¼VI, mean age¼54
years) and 492 controls (mean age¼ 56 years). This new
set included 127 cases and 138 controls already used in the
first step of our study. We initially tested the new set for two
short tandem repeats (STRs) already reported as being
associated with AGA–polyglutamine-encoding CAG repeat
and the polyglycine-encoding GGN repeat (Ellis et al.,
2001)—and for rs6152 (A/G) as described by La Spada
et al. (1991) and Hillmer et al. (2005). We detected 16 alleles
for CAG and 10 for GGN. AGA had not been associated with
a particular allele but with groups of alleles on the basis
of repeat number. We divided alleles into long and short
classes on the basis of previously published findings
(Ellis et al., 2001).
Case–control analysis performed on the whole sample
(492 cases and 492 controls) showed a very strong asso-
ciation with polymorphism rs6152 (P¼4.17e12; G-allele
kinship-corrected frequencies cases¼0.92, controls¼0.76),
whereas on CAG and GGN repeats, the association with
AGA was weaker but still significant (P¼0.01 and
P¼0.0004, respectively). These results seem to contrast with
those recently published by Ellis et al. (2007); however, we
believe that none of these triplets is actually causative but that
the association could be due to the higher linkage disequili-
brium (LD) present in our population.
To study EDA2R, we sequenced all its exons and the
50- and 30-UTR (untranslated region) regions for 20 cases and
20 controls randomly chosen from the whole sample. We
found only an informative nsSNP on exon 2: rs1385699
(C/T), which causes the substitution of arginine with lysine
on amino acid 57, and four additional informative SNPs
in the 50-UTR (rs4827380, rs12855916, rs11093958, and
rs1485682) that were all in complete LD with rs1385699 in
all 40 samples. Genotypes for this SNP were obtained using
Applied Biosystems TaqMan SNP Genotyping Assays.
rs1385699 was revealed to have the strongest association,
with a P-value of 3.9e19 (T-allele kinship-corrected frequen-
cies cases¼0.92, controls¼0.7), odds ratio 4.65 (95% confi-
dence intervals; 3.15–6.87). rs12558842 resulted in strong
association with AGA (P-value 7.6e14); it is, however, in
very strong LD with rs1385699. The role of the amino acid in
position 57 in EDA2R protein is not defined, but it is located
in a cysteine-rich domain (Yan et al., 2000). Both amino acids
have a polar basic chain, but the N-terminal group on Arg
is bigger and is more basic and could influence the protein’s
activity. Two receptors for EDA were found that are specific
for the two isoforms EDA-A1 and EDA-A2: EDAR and
EDA2R, respectively. EDA-A1 and its receptor EDAR are
capable of activating the NF-kB pathway and are implicated
in hair growth (Botchkarev and Fessing, 2005). EDA2R is
capable of activating the NF-kB pathway and also through
TRAF3,6, JNK (c-Jun N-terminal kinase) (Sinha et al., 2002),
which activates c-Jun. Mutations in EDA and EDAR give rise
to ectodermal dysplasia, a clinical syndrome characterized
by loss of hair, sweat glands, and teeth, whereas mutations in
EDA2R do not (Monreal et al., 1999; Naito et al., 2002;
Newton et al., 2004). Recently, a preliminary report
suggested that EDAR may influence hair thickness in
Asians (A. Fujimoto, R. Kimura, J. Ohashi, U. Samakkarn,
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Figure 1. Association results on X chromosome. The upper figure shows
the log10(p) for all the SNPs tested on the whole chromosome. The lower
figure shows enlargement of the most significant region. The LD (D0) plot
is shown below. The solid bars represent the genes.
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W. Settheetham-Ishida, T. Ishida, Y. Morishita, T. Furusawa,
M. Nakazawa, R. Ohtsuka, R. Yuliwulandari, L. Batubara,
M.S. Mustofa, K. Tokunaga, A scan for genetic determinants
of human hair morphology: EDAR is associated with Asian
hair thickness, ASHJ Meeting 2007). EDA2R could influence
the onset of AGA through the activation of the NF-kB
pathway or by c-Jun, which has been shown to be critical for
AR transactivation (Bubulya et al., 1996). Moreover, in adult
mice, EDA2R is also expressed in the hair bulb and in
differentiating hair matrix (Botchkarev and Fessing, 2005).
Looking at the human expression data from the UniGene
database (http://www.ncbi.nlm.nih.gov/sites/entrez), we no-
ticed that it is expressed during embryonic life and,
especially, in the first weeks after birth. Expression then
seems to be absent until the 17th year of age, when it recurs
in different tissues, including skin. This expression pattern fits
very well with the course of AGA, with its onset around
puberty.
Our study shows that AR and EDA2R are significantly
associated with AGA. However, there is some LD between
the two most associated markers for each gene (rs6152,
rs1385699: D0 ¼ 0.74, r2¼ 0.43). To test if they are indepen-
dently associated, we conditioned the analysis of each gene
to the other one. We used the UNPHASED software
(Dudbridge, 2003), which permits the association of a marker
to be conditioned to the presence of another marker. The
analysis of rs1385699 conditioned to the presence of rs6152
gave a very significant P-value of 6.136e9, whereas when
we conditioned the analysis of rs6152 to the presence of
rs1385699 the P-value was 0.04. Again, rs1385699 condi-
tioned to the presence of rs12558842 gave a very significant
result (P-value 0.007), whereas rs12558842 conditioned to
the presence of the EDA2R variant did not give a significant
result (P-value 0.06). These results show that in our
population, the EDA2R gene variation causes susceptibility
to AGA. The conditioned analysis suggests that markers on
the AR gene could be associated because of LD. However,
we cannot exclude that other variants in LD with both genes
(that is, regulatory elements of either or both genes) could be
associated with AGA. Moreover, the functional importance of
AR has already been proven by many means, and its
involvement in this pathology cannot be excluded. Further
functional and genetic studies are needed to clarify the role of
these two genes and their possible interactions in the etiology
of AGA.
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SUPPLEMENTARY MATERIAL
Table S1. Association results of the SNPs in the EDA2R/AR region in 200 cases
and 200 controls.
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